Effects of pegylated interferon on T cell receptor fingerprints in chronic hepatitis B patients with/without surface antigen clearance

Table 1 Baseline characteristics of the enrolled patients

Indexes	Group-C (n = 3)	Group-NC (n = 3)	t value	P value
Age (year)	40.00 ± 7.55	40.67 ± 8.33	-0.10	0.92
Male (n)	3	3	/	1.00
HBsAg (media, mIU/mL)	288.88 ± 208.75	106.44 ± 52.69	1.47	0.22
HBeAg (S/CO)	0.43 ± 0.05	0.54 ± 0.23	-0.82	0.47
Anti-HBc (S/CO)	7.96 ± 1.18	8.98 ± 1.14	-1.08	0.34
HBV DNA < 50 IU/mL (%)	100 (3/3)	100 (3/3)	/	1.00
ALT (U/L)	30.33 ± 17.21	23.67 ± 4.73	0.65	0.55
Total bilirubin (μmol/L)	16.77 ± 2.48	13.83 ± 1.32	1.81	0.15
Cirrhosis (%)	0 (0/3)	0 (0/3)	/	1.00

ALT: Alanine aminotransferase; Anti-HBc: Anti-hepatitis B core; HBV: Hepatitis B virus; HBsAg: Hepatitis B surface antigen; HBeAg: Hepatitis B envelop antigen.